Atlas Trials

Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Inhalation to Improve Host Defense and Pulmonary Barrier Restoration

Clinical trial NCT02595060 · COMPLETED

Trial details

NCT number
NCT02595060
Sponsor
University of Giessen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
ARDS
Start date
2016-06-01
Primary completion
2021-09-22
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.